Acquisition of Cold Chain Technologies

Industrial
Acquisition of Cold Chain Technologies

Summary

Baird served as the exclusive financial advisor to Aurora Capital Partners on this transaction

About

Aurora Capital Partners (“Aurora”) has entered into a definitive agreement to acquire Cold Chain Technologies (“CCT” or the “Company”). Terms of the transaction were not disclosed.

Aurora is a leading private equity firm that focuses principally on control investments in middle- market companies with leading market positions, stable industry dynamics, attractive business model characteristics and actionable opportunities for growth in partnership with management. Aurora provides unique resources to its portfolio companies through its Strategy & Operations Program and its team of experienced operating advisors. Aurora’s investors include leading public and corporate pension funds, endowments and foundations active in private equity investing. This transaction marks the seventh investment from Aurora Equity Partners V, which has $1.2 billion in commitments, and the fifth investment from this fund where Aurora is partnering with a founder or founder family. Aurora is based in Los Angeles, California.

CCT is a leading global provider of single-use and reusable passive thermal packaging solutions that ensure reliable shipment of temperature-sensitive materials, principally serving the life sciences supply chain. The Company's products are used in many segments of the life sciences industry, including commercial manufacturing, pharmaceutical distribution, clinical trials, specialty pharmacy deliveries and direct-to-patient shipments. CCT was founded in 1967 and is based in Franklin, Massachusetts.
CONTACT US TO LEARN MORE
Industrial
Acquisition of Cold Chain Technologies
Date
July 2019
Company
Aurora Capital Partners
Transaction
M&A
Sectors
Industrial
Target Location
North America
Acquiror Location
North America

Share